By creating a new medical modality of remote-controlled micro-robots called Bionauts™ we can transform the way the biopharmaceutical industry develops treatments, allowing us to engineer the therapeutic index for efficacy and maintain safety.
Location: United States, California, Los Angeles
Employees: 11-50
Total raised: $63.2M
Founded date: 2016
Investors 12
Show more
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.12.2022 | Series B | $43.2M | Khosla Ven... |
| 03.03.2021 | - | $20M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Daniel | Geffken | Interim Ch... | linkedin.c... | - | - |
Mentions in press and media 20
| Date | Title | Description |
| 07.07.2023 | Изобретатели Apple Face ID стоимостью $400 млн. создали крошечного робота для лечения заболеваний мозга | 7.07.23 г. Микроробот, разработанный израильскими основателями PrimeSense, может доставлять лекарства через гематоэнцефалический барьер 0 Обсудить 8 просмотров СКРИНШОТ Шпигельмахер, генеральный директор Bionaut Labs, говорит, что он понял,... |
| 05.12.2022 | Nano Robot Company Bionaut Labs Closes $43M Funding Round | - |
| 02.12.2022 | Bionaut Labs Gets $43M For Micro Robotics | Los Angeles-based Bionaut Labs, a company developing microscale robots for treating central nervous system (CNS) diseases and disorders, said this week that it has raised $43.2M in a Series B funding. The funding was led by Khosla Ventures,... |
| 29.11.2022 | Bionaut Labs Closes $43 Million in Series B Led by Khosla Ventures to Advance First-in-Class Micro-Robotic Technology | Bionaut treatment platform deploys remote-controlled microscale robots capable of delivering therapies locally to inaccessible disease areas, including the midbrain Funding supports pre-clinical and clinical research, expansion of clinical ... |
| 28.11.2022 | Bionaut Labs gets $43.2M for its tiny drug delivery robots | Founded in 2017, Bionaut Labs arrived out of stealth in March 2021, with plans to commercialize longstanding research around drug delivery robots. The Los Angeles-based startup today followed up its initial $20 million funding announcement ... |
| 28.11.2022 | Bionaut Labs closes $43M to advance first-in-class drug-carrying micro-robots for treating CNS diseases | - |
| 28.11.2022 | Bionaut Labs Closes $43M Series B Funding | Bionaut Labs, a Los Angeles, CA-based company that uses microscale robots to improve the treatment of central nervous system (CNS) diseases and disorders, raised $43M in Series B funding. The round was led by Khosla Ventures with participat... |
| 28.11.2022 | Bionaut Labs Closes $43M in Series B | LOS ANGELES, CA, Bionaut Labs announced $43.2M in a Series B round of financing led by Khosla Ventures. >> Click here for more funding data on Bionaut Labs >> To export Bionaut Labs funding data to PDF and Excel, click here ... |
| 23.06.2021 | Bionaut Moves Forward with Treatment for Brain and Spinal Tumors | People who suffer from a rare disease that produces tumors inside the brain and spinal cord are one step closer to getting a potentially less invasive treatment that rivals radiation therapy on the market. Bionaut Labs, the Los Angeles star... |
| 08.03.2021 | Bionaut Labs Launches With $20 Million in Funding | - |
Show more